REG - JPMorgan Sec.Plc Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Takeda Pharma Co Ltd amendment

Takeda Pharmaceutical CoAnnouncement

18/07/2018 17:25

RNS Number : 0850V
JPMorgan Securities Plc
18 July 2018
 


AMENDMENT
INCREASED EQUITY SALES BY 13,100 TO 45,800
ADDED EQUITY SWAP PURCHASES OF 1,259
ADDED EQUITY SWAP SALES OF 3,517
FORM 8.5 (EPT/RI)
 
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Name of exempt principal trader:


J.P. Morgan Securities Plc




(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(c) Name of the party to the offer with which exempt principal trader is connected:


Joint Financial Adviser to Takeda Pharmaceutical Company Limited




(d) Date dealing undertaken:


03 July 2018




(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
     If it is a cash offer or possible cash offer, state "N/A"


Yes, Shire plc
 



 
2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 



Class of relevant security


Purchases/ sales
 


Total number of securities


Highest price per unit paid/received
(JPY)


Lowest price per unit paid/received
(JPY)




Common Stock


Purchases
 
Sales


44,600
 
45,800


4598.0000
 
4598.0000


4558.7975
 
4558.7975



 
(b)        Cash-settled derivative transactions
 



Class of relevant security


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit
 
 




Common Stock


Equity Swaps


Long
 
 
 
 
 
 
 
 
 
 
 
 
 
Short


252
1,259
1,007
200
1,400
1,000
700
400
46,100
500
100
17
3,500
 
200
200
3,100
200
15,700
400
25,800
1,500
500
100
2,500
200
7,034


41.0556 USD
41.0582 USD
41.0586 USD
4,552.7496 JPY
4,557.9286 JPY
4,558.4000 JPY
4,562.5714 JPY
4,563.0437 JPY
4,563.5278 JPY
4,565.1434 JPY
4,574.0000 JPY
4,575.0000 JPY
4,577.6000 JPY
 
4,553.0000 JPY
4,556.5000 JPY
4,559.3798 JPY
4,561.1500 JPY
4,561.5414 JPY
4,562.1250 JPY
4,564.9186 JPY
4,565.1333 JPY
4,565.1440 JPY
4,567.0000 JPY
4,567.4120 JPY
4,574.0000 JPY
4,584.4538 JPY



 
(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit
 


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit
 





































 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit
 




















 
 



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)








 
 











 
3.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




None
 
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




None
 



 
 



Date of disclosure:


18 July 2018




Contact name:


Alwyn Basch




Telephone number:


020 7742 7407



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERBLGDRIBBBGII